Search

Conozca las últimas investigaciones sobre la acupuntura en MSK y cómo nuestros investigadores están estudiando los beneficios de la acupuntura para aliviar los efectos secundarios del cáncer y sus terapias.

… Monday, July 22, 2024 La acupuntura, una forma de medicina tradicional china, se ha utilizado como tratamiento médico durante más de 2500 años. Los investigadores del  Servicio de Medicina Integral del Memorial Sloan Kettering Cancer Center (MSK) están estudiando la ciencia de la acupuntura para determinar

By uncovering the root cause of cytokine release syndrome, MSK researchers have found a way to stop it.

… Monday, May 28, 2018 Summary Researchers at the Sloan Kettering Institute have identified the cause of a serious immunotherapy side effect as well as ways to stop or prevent it. The study was done in mice but the approach will soon be tested in people. CAR T cell therapy CAR T cell therapy is helping

A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly.

… Thursday, May 29, 2025 More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer. Now, a team of researchers from Memorial Sloan Kettering Cancer

Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, June 7, 2024 Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK). E-nose diagnostic predictions agreed with histopathological results in 86% of 100

Researchers find an epigenetic role in how breast cancer tumors develop resistance to treatment.

… Thursday, March 23, 2017 Summary Many breast cancers rely on a disease pathway called PI3K, so drugs have been developed to inhibit this pathway. However, after responding initially to PI3K inhibitors, these tumors often activate another pathway, called ER, to begin growing again. A new finding reveals

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.

… Monday, July 17, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers;

Meet Cancer Engineering MD-PhD candidate Brandon Cuevas: “Being able to be a bridge between medicine and research is such a privilege, one that not many places can offer.”

… Friday, June 6, 2025 Brandon Cuevas was just a sophomore in high school when he set his sights on becoming a physician-scientist at Memorial Sloan Kettering Cancer Center (MSK). “My aunt was diagnosed with stage 3 breast cancer,” says Brandon, who grew up in and around New York City. “It was the first

Dr. Hedvig Hricak is leading an international commission calling for a global strategy on improving access to more effective cancer care.

… Thursday, March 4, 2021 An international Commission of nuclear medicine and medical imaging experts led by Dr. Hedvig Hricak , Chair of Memorial Sloan Kettering’s Department of Radiology, recently released data from the first ever report that quantified imaging and nuclear medicine resources worldwide

During meiosis, small chromosomes risk being lost in the shuffle. Here’s how they hold their own.

… Wednesday, May 6, 2020 Summary Scientists at the Sloan Kettering Institute have solved the puzzle of how small chromosomes ensure that they aren’t skipped over during meiosis, the process that makes sperm and egg. From avocado plants to baker’s yeast, humans to zebras, sexually reproducing organisms

A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.

… Friday, December 7, 2012 A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC).  The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein. The new program, called the David M. Rubenstein